Certified by Founder Lodge
D3 Bio
China - ND
START UP
1 Disclosed Funding Rounds $108,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Biotechnology company focusing on development and registration of innovative medicines in oncology and immunology.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 11 ,2025 | Series B | $108,000,000 |
IDG Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Yonda | $15,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
